Vicky S. Sabine

702 total citations
13 papers, 343 citations indexed

About

Vicky S. Sabine is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Vicky S. Sabine has authored 13 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Vicky S. Sabine's work include PI3K/AKT/mTOR signaling in cancer (5 papers), Breast Cancer Treatment Studies (4 papers) and Advanced Breast Cancer Therapies (3 papers). Vicky S. Sabine is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (5 papers), Breast Cancer Treatment Studies (4 papers) and Advanced Breast Cancer Therapies (3 papers). Vicky S. Sabine collaborates with scholars based in United Kingdom, Canada and United States. Vicky S. Sabine's co-authors include John M.S. Bartlett, Andrew H. Sims, J. Michael Dixon, Lorna Renshaw, Jeremy Thomas, E. Jane Macaskill, J. Michael Dixon, Tammy Piper, Cassandra Brookes and Christos Markopoulos and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Vicky S. Sabine

13 papers receiving 338 citations

Peers

Countries citing papers authored by Vicky S. Sabine

Since Specialization

Citations

This map shows the geographic impact of Vicky S. Sabine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vicky S. Sabine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vicky S. Sabine more than expected).

Fields of papers citing papers by Vicky S. Sabine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vicky S. Sabine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vicky S. Sabine. The network helps show where Vicky S. Sabine may publish in the future.

Co-authorship network of co-authors of Vicky S. Sabine

This figure shows the co-authorship network connecting the top 25 collaborators of Vicky S. Sabine. A scholar is included among the top collaborators of Vicky S. Sabine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vicky S. Sabine. Vicky S. Sabine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Tumour sampling method can significantly influence gene expression profiles derived from neoadjuvant window studies 2016 ·Scientific Reports ·(unknown), Laura Arthur, Arran Turnbull, Lorna Renshaw, Vicky S. Sabine, Jeremy Thomas, John M.S. Bartlett, J. Michael Dixon, Andrew H. Sims	12
2	KRAS Mutations in Canine and Feline Pancreatic Acinar Cell Carcinoma 2016 ·Journal of Comparative Pathology ·(unknown), Geoffrey A. Wood, Robert A. Foster, (unknown), (unknown), John M.S. Bartlett, Brenda L. Coomber, Vicky S. Sabine	8
3	Abstract S2-01: Theranostic multiparametric tests improve residual risk assessment in early luminal breast cancer 2015 ·Cancer Research ·John M.S. Bartlett, Vicky S. Sabine, Syed Haider, Camilla Drake, (unknown), Cindy Q. Yao, Cassandra Brookes, Cornelis JH van de Velde, Annette Hasenburg, D. G. Kieback, Christos Markopoulos, Luc Dirix, Caroline Seynaeve, Daniel Rea, Paul C. Boutros	1
4	Mutational Analysis of PI3K/AKT Signaling Pathway in Tamoxifen Exemestane Adjuvant Multinational Pathology Study 2014 ·Journal of Clinical Oncology ·Vicky S. Sabine, (unknown), Cassandra Brookes, Camilla Drake, Tammy Piper, Cornelis J.�H. van de Velde, Annette Hasenburg, D. G. Kieback, Christos Markopoulos, Luc Dirix, Caroline Seynaeve, Daniel Rea, John M.S. Bartlett	86
5	PIK3CA Genotype and a PIK3CA Mutation-Related Gene Signature and Response to Everolimus and Letrozole in Estrogen Receptor Positive Breast Cancer 2013 ·PLoS ONE ·Sherene Loi, Stefan Michiels, José Baselga, Thomas John, Sandeep K. Singhal, Vicky S. Sabine, Andrew H. Sims, Tarek Sahmoud, J. Michael Dixon, Martine Piccart, Christos Sotiriou	67
6	Relative impact of key sources of systematic noise in Affymetrix and Illumina gene-expression microarray experiments 2011 ·BMC Genomics ·Robert R. Kitchen, Vicky S. Sabine, Arthur A. Simen, J. Michael Dixon, John M.S. Bartlett, Andrew H. Sims	20
7	Response to mTOR inhibition: activity of eIF4E predicts sensitivity in cell lines and acquired changes in eIF4E regulation in breast cancer 2011 ·Molecular Cancer ·(unknown), Victoria Cookson, (unknown), Nicola Ingram, Brijesh Madhok, Andrew M. Hanby, (unknown), Vicky S. Sabine, E. Jane Macaskill, John M.S. Bartlett, J. Michael Dixon, Jim McElwaine, Thomas A. Hughes	23
8	The mammalian target of rapamycin inhibitor everolimus (RAD001) in early breast cancer: results of a pre-operative study 2010 ·Breast Cancer Research and Treatment ·E. Jane Macaskill, John M.S. Bartlett, Vicky S. Sabine, Dana Faratian, Lorna Renshaw, (unknown), Fiona Campbell, (unknown), Linda Williams, Jeremy Thomas, Matthew Barber, J. Michael Dixon	40
9	Gene expression profiling of response to mTOR inhibitor everolimus in pre-operatively treated post-menopausal women with oestrogen receptor-positive breast cancer 2010 ·Breast Cancer Research and Treatment ·Vicky S. Sabine, Andrew H. Sims, E. Jane Macaskill, Lorna Renshaw, Jeremy Thomas, J. Michael Dixon, John M.S. Bartlett	37
10	Correcting for intra-experiment variation in Illumina BeadChip data is necessary to generate robust gene-expression profiles 2010 ·BMC Genomics ·Robert R. Kitchen, Vicky S. Sabine, Andrew H. Sims, E. Jane Macaskill, Lorna Renshaw, Jeremy Thomas, Jano van Hemert, J. Michael Dixon, John M.S. Bartlett	26
11	GENE EXPRESSION PROFILING OF ER-POSITIVE BREAST TUMOURS FROM POST-MENOPAUSAL WOMEN TREATED WITH NEOADJUVANT RAD001 2009 ·Andrew H. Sims, Vicky S. Sabine, E. Jane Macaskill, Lorna Renshaw, (unknown), J. Michael Dixon, J. M. S. Bartlett	1
12	Expression of Tumor Necrosis Factor α Converting Enzyme in Endocrine Cancers 2008 ·American Journal of Clinical Pathology ·Tove Kirkegaard, Anjali Naresh, Vicky S. Sabine, Sian Tovey, Joanne Edwards, Barbara Dunne, Timothy G. Cooke, Frank E. Jones, John M.S. Bartlett	8
13	The GENIPOL European flounder Platichthys flesus L. toxicogenomics microarray: application for investigation of the response to furunculosis vaccination 2008 ·Journal of Fish Biology ·Amer M. Diab, Tim Williams, Vicky S. Sabine, James Kevin Chipman, S.G. George	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact